Q4 2016

Latest Quarterly Results
Ended June 30, 2016

$806,578

Research and development YTD

$2,205,144

Net cash used in operations YTD

Stock Snapshot

Propanc Health Group Corporation OTCQB: PPCH
Change/Percentage
Day Range
52 Week Range
Volume
Detailed Quote Stock Charts Historical Quote